Drawing for SHERPAPERFUSION

USPTO serial 87471679

SHERPAPERFUSION

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
CROWLEY, PAUL
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SHERPAPERFUSION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010A portable system for transporting a recovered organ, tissue, or cells from a recovery location to a transplant or processing centerABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2018MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
May 7, 2018ABN5ABANDONMENT - AFTER PUBLICATION
May 1, 2018EXARTEAS EXPRESS ABANDONMENT RECEIVED
Apr 26, 2018ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 16, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Oct 17, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 1, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2017DOCKASSIGNED TO EXAMINER
Jun 8, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance